Found 4 hits for monomerid = 476815 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
D(3) dopamine receptor
(Homo sapiens (Human)) | BDBM476815
![PNG](/data/jpeg/tenK47/BindingDB_476815.png) (US10870660, Compound III-274 | US11345716, Compoun...)Show SMILES Cc1ncc(\C=C\C(=O)N[C@H]2CC[C@H](CCN3CCc4nc(OCC(F)F)sc4CC3)CC2)s1 |r,wU:13.13,wD:10.9,(13.78,3.89,;12.24,3.89,;11.33,5.14,;9.87,4.66,;9.87,3.12,;8.53,2.35,;7.2,3.12,;5.87,2.35,;5.87,.81,;4.53,3.12,;3.2,2.35,;1.87,3.12,;.53,2.35,;.53,.81,;-.8,.04,;-2.14,.81,;-3.47,.04,;-4.74,.91,;-6.21,.46,;-6.78,-.98,;-8.28,-1.3,;-8.44,-2.83,;-9.78,-3.6,;-11.11,-2.83,;-12.44,-3.6,;-12.44,-5.14,;-13.78,-2.83,;-7.04,-3.46,;-6.01,-2.31,;-4.48,-2.54,;-3.35,-1.49,;1.87,.04,;3.2,.81,;11.33,2.65,)| Show InChI InChI=1S/C24H32F2N4O2S2/c1-16-27-14-19(33-16)6-7-23(31)28-18-4-2-17(3-5-18)8-11-30-12-9-20-21(10-13-30)34-24(29-20)32-15-22(25)26/h6-7,14,17-18,22H,2-5,8-13,15H2,1H3,(H,28,31)/b7-6+/t17-,18- | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| PC cid PC sid UniChem
| US Patent
| 0.120 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SHIONOGI & CO., LTD.
US Patent
| Assay Description 225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent... |
US Patent US10870660 (2020)
|
More data for this Ligand-Target Pair | |
D(3) dopamine receptor
(Homo sapiens (Human)) | BDBM476815
![PNG](/data/jpeg/tenK47/BindingDB_476815.png) (US10870660, Compound III-274 | US11345716, Compoun...)Show SMILES Cc1ncc(\C=C\C(=O)N[C@H]2CC[C@H](CCN3CCc4nc(OCC(F)F)sc4CC3)CC2)s1 |r,wU:13.13,wD:10.9,(13.78,3.89,;12.24,3.89,;11.33,5.14,;9.87,4.66,;9.87,3.12,;8.53,2.35,;7.2,3.12,;5.87,2.35,;5.87,.81,;4.53,3.12,;3.2,2.35,;1.87,3.12,;.53,2.35,;.53,.81,;-.8,.04,;-2.14,.81,;-3.47,.04,;-4.74,.91,;-6.21,.46,;-6.78,-.98,;-8.28,-1.3,;-8.44,-2.83,;-9.78,-3.6,;-11.11,-2.83,;-12.44,-3.6,;-12.44,-5.14,;-13.78,-2.83,;-7.04,-3.46,;-6.01,-2.31,;-4.48,-2.54,;-3.35,-1.49,;1.87,.04,;3.2,.81,;11.33,2.65,)| Show InChI InChI=1S/C24H32F2N4O2S2/c1-16-27-14-19(33-16)6-7-23(31)28-18-4-2-17(3-5-18)8-11-30-12-9-20-21(10-13-30)34-24(29-20)32-15-22(25)26/h6-7,14,17-18,22H,2-5,8-13,15H2,1H3,(H,28,31)/b7-6+/t17-,18- | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| PC cid PC sid UniChem
| | 0.120 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this Ligand-Target Pair | |
D(2) dopamine receptor
(Homo sapiens (Human)) | BDBM476815
![PNG](/data/jpeg/tenK47/BindingDB_476815.png) (US10870660, Compound III-274 | US11345716, Compoun...)Show SMILES Cc1ncc(\C=C\C(=O)N[C@H]2CC[C@H](CCN3CCc4nc(OCC(F)F)sc4CC3)CC2)s1 |r,wU:13.13,wD:10.9,(13.78,3.89,;12.24,3.89,;11.33,5.14,;9.87,4.66,;9.87,3.12,;8.53,2.35,;7.2,3.12,;5.87,2.35,;5.87,.81,;4.53,3.12,;3.2,2.35,;1.87,3.12,;.53,2.35,;.53,.81,;-.8,.04,;-2.14,.81,;-3.47,.04,;-4.74,.91,;-6.21,.46,;-6.78,-.98,;-8.28,-1.3,;-8.44,-2.83,;-9.78,-3.6,;-11.11,-2.83,;-12.44,-3.6,;-12.44,-5.14,;-13.78,-2.83,;-7.04,-3.46,;-6.01,-2.31,;-4.48,-2.54,;-3.35,-1.49,;1.87,.04,;3.2,.81,;11.33,2.65,)| Show InChI InChI=1S/C24H32F2N4O2S2/c1-16-27-14-19(33-16)6-7-23(31)28-18-4-2-17(3-5-18)8-11-30-12-9-20-21(10-13-30)34-24(29-20)32-15-22(25)26/h6-7,14,17-18,22H,2-5,8-13,15H2,1H3,(H,28,31)/b7-6+/t17-,18- | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| PC cid PC sid UniChem
| | 140 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this Ligand-Target Pair | |
D(2) dopamine receptor
(Homo sapiens (Human)) | BDBM476815
![PNG](/data/jpeg/tenK47/BindingDB_476815.png) (US10870660, Compound III-274 | US11345716, Compoun...)Show SMILES Cc1ncc(\C=C\C(=O)N[C@H]2CC[C@H](CCN3CCc4nc(OCC(F)F)sc4CC3)CC2)s1 |r,wU:13.13,wD:10.9,(13.78,3.89,;12.24,3.89,;11.33,5.14,;9.87,4.66,;9.87,3.12,;8.53,2.35,;7.2,3.12,;5.87,2.35,;5.87,.81,;4.53,3.12,;3.2,2.35,;1.87,3.12,;.53,2.35,;.53,.81,;-.8,.04,;-2.14,.81,;-3.47,.04,;-4.74,.91,;-6.21,.46,;-6.78,-.98,;-8.28,-1.3,;-8.44,-2.83,;-9.78,-3.6,;-11.11,-2.83,;-12.44,-3.6,;-12.44,-5.14,;-13.78,-2.83,;-7.04,-3.46,;-6.01,-2.31,;-4.48,-2.54,;-3.35,-1.49,;1.87,.04,;3.2,.81,;11.33,2.65,)| Show InChI InChI=1S/C24H32F2N4O2S2/c1-16-27-14-19(33-16)6-7-23(31)28-18-4-2-17(3-5-18)8-11-30-12-9-20-21(10-13-30)34-24(29-20)32-15-22(25)26/h6-7,14,17-18,22H,2-5,8-13,15H2,1H3,(H,28,31)/b7-6+/t17-,18- | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| PC cid PC sid UniChem
| US Patent
| 140 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SHIONOGI & CO., LTD.
US Patent
| Assay Description 225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent... |
US Patent US10870660 (2020)
|
More data for this Ligand-Target Pair | |